Pancreatic Cancer Drug Doubles Survival, Warriors Eye Major Moves

Tuesday June 02, 2026

In this episode, we delve into groundbreaking medical news and local sports developments in San Francisco. A new experimental drug, daraxonrasib, shows promise in nearly doubling survival rates for patients with advanced pancreatic cancer, offering hope for those battling this challenging disease. Meanwhile, the Golden State Warriors are gearing up for a transformative offseason, with star player Steph Curry anticipating significant roster changes as the team evaluates draft prospects and considers strategic trades, including Draymond Green's potential player option decision.

On the local front, the San Francisco Giants face a tough series against Milwaukee, with hopes of bouncing back after a recent loss. The Giants' manager Tony Vitello, in his first year, brings a unique college-to-pros perspective to the team. Weather conditions at Ocean Beach promise fair surfing opportunities, with waves ranging from three to five feet in the morning before choppy conditions set in later.

Additionally, we touch on national financial trends, including the latest in cryptocurrency movements and innovative AI tools aiding job seekers in salary negotiations. Join us as we explore these dynamic stories shaping San Francisco and beyond.

@sunnymorningsmedia